SEC FORM 3/A SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Ozeki Arthur

(Last) (First) (Middle)
16600 SWINGLEY RIDGE ROAD

(Street)
CHESTERFIELD MO 63017

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/16/2024
3. Issuer Name and Ticker or Trading Symbol
REINSURANCE GROUP OF AMERICA INC [ RGA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Head of Asia Pacific
5. If Amendment, Date of Original Filed (Month/Day/Year)
01/10/2024
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Right (right to purchase) 2017 (1) 03/03/2027 Common Stock 1,401 129.72 D
Stock Appreciation Right (right to purchase) 2018 (1) 03/02/2028 Common Stock 1,222 150.87 D
Stock Appreciation Right (right to purchase) 2019 (1) 03/01/2029 Common Stock 1,503 142.25 D
Stock Appreciation Right (right to purchase) 2020 (1) 03/06/2030 Common Stock 3,871 117.85 D
Stock Appreciation Right (right to purchase) 2021 (1) 03/11/2031 Common Stock 1,696 129.01 D
Stock Appreciation Right (right to purchase) 2022 (1) 03/22/2032 Common Stock 3,108 106.53 D
Stock Appreciation Right (right to purchase) 2023 (1) 03/09/2033 Common Stock 1,690 138.34 D
Restricted Share Unit - March 2021 12/31/2023 (2) Common Stock 459 129.01 D
Restricted Share Unit - March 2022 12/31/2024 (3) Common Stock 891 106.53 D
Restricted Share Unit - March 2023 12/31/2025 (4) Common Stock 576 138.34 D
Explanation of Responses:
1. SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant.
2. Restricted share units granted on March 11, 2021, fully vest on December 31, 2023.
3. Restricted share units granted on March 22, 2022, fully vest on December 31, 2024.
4. Restricted share units granted on March 9, 2023, fully vest on December 31, 2025.
Remarks:
/s/ William L. Hutton, by Power of Attorney 01/16/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.